These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38593386)

  • 21. Association between urologic malignancies and end-stage renal disease: A meta-analysis.
    Kompotiatis P; Thongprayoon C; Manohar S; Cheungpasitporn W; Gonzalez Suarez ML; Craici IM; Mao MA; Herrmann SM
    Nephrology (Carlton); 2019 Jan; 24(1):65-73. PubMed ID: 29236344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis, therapy and prognosis of urologic tumors in the aged].
    Guddat HM
    Z Alternsforsch; 1985; 40(3):155-7. PubMed ID: 4013373
    [No Abstract]   [Full Text] [Related]  

  • 23. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
    David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multidisciplinary approach to the management of urologic malignancies: does it influence diagnostic and treatment decisions?
    Kurpad R; Kim W; Rathmell WK; Godley P; Whang Y; Fielding J; Smith L; Pettiford A; Schultz H; Nielsen M; Wallen EM; Pruthi RS
    Urol Oncol; 2011; 29(4):378-82. PubMed ID: 19576797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of serum prostate-specific antigen in urologic cancers.
    Takeuchi T; Kuriyama M; Fujihiro S; Fujimoto Y; Okano M; Nishiura T
    J Surg Oncol; 1983 Oct; 24(2):157-60. PubMed ID: 6195484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Urologic malignancies in renal transplant candidates and recipients].
    Kleinclauss F; Thuret R; Murez T; Timsit MO
    Prog Urol; 2016 Nov; 26(15):1094-1113. PubMed ID: 27665407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AI-powered radiomics: revolutionizing detection of urologic malignancies.
    Gelikman DG; Rais-Bahrami S; Pinto PA; Turkbey B
    Curr Opin Urol; 2024 Jan; 34(1):1-7. PubMed ID: 37909882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How can biomarkers assist the prognosis of urologic malignancies?
    Falzarano SM; Feely MM
    Expert Rev Mol Diagn; 2020 Feb; 20(2):131-133. PubMed ID: 31495243
    [No Abstract]   [Full Text] [Related]  

  • 29. Diagnostic and therapeutic utility of monoclonal antibodies in urologic oncology.
    McCarley DL; Weiner RS
    Semin Surg Oncol; 1989; 5(4):293-301. PubMed ID: 2672236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomic studies in urological malignancies.
    Ferguson RE; Selby PJ; Banks RE
    Contrib Nephrol; 2004; 141():257-79. PubMed ID: 14650238
    [No Abstract]   [Full Text] [Related]  

  • 31. Urine microRNAs as potential noninvasive biomarkers in urologic cancers.
    Mlcochova H; Hezova R; Stanik M; Slaby O
    Urol Oncol; 2014 Jan; 32(1):41.e1-9. PubMed ID: 24035473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of microscopic hematuria in the evaluation of urologic malignancy in renal transplant recipients.
    Kim DY; Abouljoud M; Parasuraman R
    Transplant Proc; 2010 Jun; 42(5):1641-2. PubMed ID: 20620491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary Tumors of the Urinary System: An Imaging Conundrum.
    Karaosmanoglu AD; Onur MR; Karcaaltincaba M; Akata D; Ozmen MN
    Korean J Radiol; 2018; 19(4):742-751. PubMed ID: 29962880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primitive neuroectodermal tumor: rare, highly aggressive differential diagnosis in urologic malignancies.
    Ellinger J; Bastian PJ; Hauser S; Biermann K; Müller SC
    Urology; 2006 Aug; 68(2):257-62. PubMed ID: 16904430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upper urinary tract tumor in a duplicated collecting system: report of three cases and review of the literature.
    Chen KS; Chuang CK; Wu CH; Liaw CC; Lee N
    Chang Gung Med J; 2003 May; 26(5):377-82. PubMed ID: 12934856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of primary care physician density, urologist presence, and insurance status on stage of diagnosis for urologic malignancies.
    Nguyen KD; Hyder ZZ; Shaw MD; Maness SB; Cookson MS; Patel SG; Stratton KL
    Cancer Epidemiol; 2018 Feb; 52():10-14. PubMed ID: 29145004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urological Cancers and ChatGPT: Assessing the Quality of Information and Possible Risks for Patients.
    Ozgor F; Caglar U; Halis A; Cakir H; Aksu UC; Ayranci A; Sarilar O
    Clin Genitourin Cancer; 2024 Apr; 22(2):454-457.e4. PubMed ID: 38246831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Value of positron emission tomography in urological neoplasms: more form than substance?].
    Müller J; Schrader M; Schrader AJ; Höpfner M; Zengerling F
    Urologe A; 2012 Mar; 51(3):331-40. PubMed ID: 22358377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
    Rouprêt M; Yates DR; Comperat E; Cussenot O
    Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular signatures in urologic tumors.
    Larkin S; Kyprianou N
    Int J Mol Sci; 2013 Sep; 14(9):18421-36. PubMed ID: 24018887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.